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ABSTRACT 
 
 
Solid phase extraction has become a popular tool for analytical method development 
as a sample preparation technique. Solid phase sorbents can generally extract analytes 
based on polarity or selectively based on highly specific interactions between the analyte 
and an immobilized surface molecule. Biomolecular recognition based solid phases 
utilize antibodies, nucleic acids, and proteins as a secondary affinity layer on a solid 
phase support for selective analyte extractions and have been used for sample 
preparation, purification, separations, bioassays, and molecular diagnostics.  
Polymer supports for solid phase extraction are desirable for their low cost, 
abundance, chemical inertness, and pH stability. This thesis reports the use of capillary-
channel polymer (C-CP) fibers as a solid support modified for selective extraction and on 
fiber fluorescence detection of nucleic acids and proteins. The polymer fibers are low 
cost and their unique shape allows them to be easily adapted into a fluidic fiber based 
micro spin column configuration for a small scale, inexpensive, low-tech, and easy to use 
device. Platform performance was successful as demonstrated by modifying the polymer 
surface with neutravidin via adsorption to tether specific biotinylated analyte recognition 
moieties. Fluorescence resulted from either hybridization of a complementary 
fluorophore labeled probe to nucleic acids or conjugation of a fluorophore to the analyte 
protein.  
On fiber fluorescence detection of nucleic acids and proteins was successful with 
minimal non-specific binding of proteins and nucleic acids to the polymer surface. Two 
sequence specific oligonucleotides were added and probed either separately or 
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simultaneously on the fibers; the fluorescence intensity increasing with the amount of 
oligonucleotide added, leveling off at 100 pmol. Fluorescence signal never saturated for 
small volume additions (10ul) up to 100 pmol of added oligonucleotide. The LOD was 
calculated to be 100s of fmol for all experiments. For selective extraction of proteins, 
protein recovery was similar for both C-CP fibers and streptavidin conjugated magnetic 
microbeads. Adsorbed neutravidin did not irreversibly bind to the C-CP fiber surface and  
was partially removed in the presence of .01% Tween-20.  
C-CP fibers and spin columns are inexpensive, easy to use, and can be integrated as a 
solid phase extraction sample preparation step for small scale bioassays or molecular 
diagnostics. 
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CHAPTER ONE 
 
INTRODUCTION 
 
The ability to analyze the composition, quantity, and identity of certain molecular 
and biomacromolecular compounds has led to advancements in therapeutics[1-3] and 
medical diagnostics[4-8]. Direct analysis can be problematic due to interfering sample 
matrix particles and molecules that can suppress or enhance the analyte signal. Samples 
that contain trace amounts of analyte are also not suitable for direct analysis because 
they can be below the detection limit for most analytical instruments. Solid phase 
extraction has become a popular tool to analyze compounds from a variety of complex 
mixtures and biological matrices such as groundwater[9-12], urine[13, 14], and whole 
blood[15, 16]. Solid phase extraction works by extracting out the analyte of interest onto a 
solid phase sorbent that has favorable interactions with the analyte. It has been widely 
used in analytical method development as a sample preparation step, making the analyte 
of interest conducive for downstream application. Depending on the downstream 
application the analyte can be purified, isolated, or pre-concentrated. For example, water 
purification uses solid phases when extracting drugs[17], pesticides[18], and metals[19] 
from ground water. Silica particles and ion exchange resins have been used to extract 
DNA before downstream PCR analysis because the salt and protein content found in 
DNA samples (from cell lysate) can inhibit enzyme amplification[20-22]. Solid phase 
extraction has been used as a sample purification and analyte isolation prior to ESI and 
MALDI mass spectrometry detection because biological fluids are composed of many 
ions that can interfere or complicate mass spectrometry detection. The salts cause ion 
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suppression as well as forming adducts that can add more peaks which complicate 
analysis[23-26]. Pre-concentration has been used in both the environmental and forensics 
fields for trace analysis of pesticides from environmental samples[11] and for DNA from 
forensic samples[27, 28].  
Solid phases come in a variety of materials and formats depending upon the 
application. Conventional solid phase sorbents packed into cartridges, columns, and 
disks[29] are more generally selective and extract the analyte of interest based on its 
polarity and electrostatic interactions between it and the sorbent. These phases are 
classified into different modes such as normal phase, reverse phase, ion exchange, and 
mixed mode extraction[30]. Modified silica is the most used for all modes because it is 
easily modified to alter the polarity with different polar and non-polar functional groups 
such as C-18, C-8, CN, and phenols[30]. However, silica has disadvantages such as low 
pH working range and chemical instability from hydrolysis of the bonded chains, and 
the effects of the unreacted silanol groups[30, 31]. This led to carbon based solid phases 
which had better chemical stability compared to silica. Carbon solid phases such as 
carbon black and porous graphitized carbon were shown to have some degree of polarity 
and non-polarity which acted as more of a mixed mode and would extract out polar, non 
polar, and ionic substances[31]. However carbon phases irreversibly bound polar analytes 
which resulted in poor recovery[31]. Porous polymer resins[32] such as polystyrene 
divinylbenzene also have better chemical stability compared to silica however they have 
to be pretreated with polar solvents before analyte extraction from aqueous solutions 
because the polymer was hydrophobic. This led to functionalized polymer solid phases 
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linked with hydrophilic functional groups to allow aqueous solutions to make better 
contact with the resin[32].  
Silica, carbon, and polymer sorbents are only generally selective and can include 
other co-extracted interferences. This has lead to method development that includes a 
two step solid phase extraction and downstream separation to fully isolate the analyte, or 
multiple elution steps to get rid of the other co-extracted interferences[33]. Also co-
extracted interferences can also decrease binding capacity, which can be detrimental in 
trace analysis. For example, DNA and RNA have been extracted on both ion exchange 
and silica sorbents[34]. The negatively charged phosphate backbone on nucleic acids can 
be exchanged on an anion exchange phase or hydrogen bonding of nucleotide bases on a 
silica phase. However, proteins also bind to the sorbent and have to be removed in a first 
elution step with ethanol.  
Extraction efficiency is due in part to the affinity of the analyte to the solid phase 
sorbent. The introduction of selective sorbents can enhance extraction down to just a 
single analyte or a similar group of analytes. This has led to the development of selective 
solid phases based off of molecular recognition such as molecular imprinted polymers 
(MIP) and immunosorbents. MIPs operate on the principle of using template molecules 
bound to functional monomers that are polymerized around it to form cavities in the 
shape and size of the template molecule that mimic the actual natural binding sites. The 
template molecule is then extracted out of the cavity. They are desirable because the 
template holes are in the shape and size of the molecules such as small ionic molecules 
and even proteins, which give them their selectivity. They have been used for 
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environmental analysis of pesticides[35], and drugs[35, 36]. However MIPs suffer from 
disadvantages. One major one is template bleed through, meaning the template still 
remains embedded in the polymer after all the washes to extract it out of the cavity[35]. 
This disadvantage has been circumvented by the use of a similar analogue as the 
template so there will not be bleed through. MIP have also been used for protein 
extraction[37] but has disadvantages because of the unstable 3D conformations of 
proteins brought on by random motion as well as conformational changes which are 
dependent upon the ionic strength, solvent, and pH. Immunosorbents are also based on 
molecular recognition and use antibodies that have been raised against an antigen for 
selective antigen extraction[12]. Immunosorbents have found the most use in biological 
separations[38], but have also been adapted for the extraction of small molecules in 
environmental[12, 39] and food samples by using specific antibodies directed against those 
antigens[12]. Nucleic acids[40] and proteins[41] have also been used as biomolecular 
recognition ligands for solid phase extraction and have found application in areas such 
as molecular diagnostics and bioassays[7].  
Solid phases also come in a variety of configurations depending on the need, 
instrumentation, available resources, and technical skill level required. One such 
configuration is the microbead. Biological separations and extractions were 
revolutionized after the invention of the microbead in 1976 and become more popular 
when they were made magnetizable[42], which made it easier for sample handling and 
did away with instrumentation unlike agarose and dextran modified beads which had to 
be pelleted by centrifugation. The magnetic microbeads have been made with diameters 
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from tens of nanometers to hundreds of micrometers and have been used in bioassays as 
solid phase substrates[43-46]. The microbead configuration allowed for smaller scale solid 
phase extraction and affinity purification with the potential for parallel and high 
throughput applications compared to the traditional solid phase extraction configurations 
such as columns, cartridges, and disks which required larger volumes that increased 
sample processing time resulting in less throughput. The beads are scalable and can use 
smaller volumes of hundreds of microliters because the beads in conjunction with 
smaller volumes increase the available surface area available per volume for binding. 
Beads are sold either pre-coupled or modified “in house” with specific ligands such as 
protein A and G[47, 48] as well as other antibodies[48] which have been used in 
immunoassays and purifications[49, 50], along with streptavidin[43], glutathione[47, 49, 51, 52], 
nickel[51, 52], and even conventional solid phase functional groups for other small scale 
purifications or bioassays[53]. There is also polystyrene beads which allows for “in 
house” customization[54, 55].  
Microtitier plates made from various polymers (polystyrene, acrylic, PMMA) are 
another configuration that have been used as solid supports for selective extraction. One 
example is functionalizing the microtiter wells with either antigen or antibody to test for 
the presence of certain antibodies and antigens in serum. When the body is infected with 
a particular antigen, such as a virus or a particular allergen, it builds up immunity 
towards it by producing antibodies. To test for the presence of these antibodies, the 
antibodies need to be extracted out of the serum. The antibodies are extracted onto the 
immobilized antigen on the well surface and then probed with a secondary labeled 
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antibody for detection. For example, enzyme linked immunosorbent assay (ELISA) is a 
pre-screening test where diluted blood serum is applied to an immunosorbent or antigen 
modified well in a microtiter plate[56]. The immobilized antibody from the serum sample 
is then probed with a secondary antibody linked to an enzyme, and upon addition of a 
specific enzyme substrate, the solution in the well will change color if the particular 
serum antibody was present. The microtiter plate configuration allows for semi-
quantitative readout from the well, simple sample application, surface modification, and 
the ability to run parallel assays. Plus, the increased sensitivity of enzyme/substrate 
detection makes it suitable to detect very small amounts of antibody.  
Microfluidics has also found multidisciplinary use in fields of chemical synthesis[57], 
fluid delivery[58], and solid phase extraction[59]. Each field has different motivations for 
microfluidics. However, all fields find potential for automization, integration, and 
portability in these miniaturized, self-contained devices. This has led to a whole area of 
research dedicated to the miniaturization of conventional bench top procedures onto a 
single chip for a total analysis system[60] known as “lab-on-a-chip.” There has been an 
ongoing effort to develop simpler designs in order to make more easily used diagnostic 
devices to become more widespread making there way from centralized laboratories to 
point of care facilities such as clinical facilities and hospitals. Ultimately, the ideal goal 
is to have a “plug and play” device that can be used for as a total analysis system. Part of 
that total analysis is to incorporate solid phase extraction into the chip. There has been 
research done that has incorporated silica beads, sol-gels, and polymer monoliths into 
microchannels for the extraction of nucleic acids[6, 34, 61-71]. This has allowed for less 
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sample handling which reduces contamination, and has expedited analysis time due to 
minimal sample volumes needed as well as low elution volumes for nucleic acid 
enrichment. There has also been research done where amplification is incorporated on 
the chip using various temperature cycling strategies such as miniature heaters, chemical 
reactions, as well as just using isothermal amplification[70, 72-75]. Integrating extraction 
and amplification on-chip reduces the risk of sample contamination and degradation of 
the nucleic acids.  
There has been an ongoing effort to also develop fluidic type devices using low cost, 
abundant materials that require very little technical skill and instrumentation. In a low 
resource setting or on-site testing there will most likely not be a skilled technician or 
instruments needed to handle sample processing and analysis so a practical alternative 
would be a rapid, integrated, and portable design with direct extraction from biological 
fluids and visual detection (i.e. colorimetric detection) preferably, on a cheap solid 
support. There has been research using paper or nitrocellulose membranes for 
microfluidic chips and lateral flow assays for this purpose coupled with probes for 
colorimetric detection[76-83].  
There has already been some research using electrospun fibers as well as polyester, 
cotton, silk, and cellulose thread as material for solid phase extraction and fluid 
transport[84-103] as an ongoing effort to design simple, cheap, low-tech fluidic devices. 
The fiber platform used in the following studies is made possible by production of 
capillary channel polymer (C-CP) fibers that are made from textile materials extruded 
from a variety of low cost polymers that include polypropylene (PP), polyester, and 
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nylon. The shape and geometry of the individual fibers is unique and determined by their 
extrusion; we have been working with PP fibers extruded with a series of eight open 
channels. Although PP is highly hydrophobic which does not easily wick fluid, however, 
when packed together the interdigitation of shaped fibers creates micron-sized channels 
with efficient fluid transport and high surface area that still promote fluid wicking for 
aqueous solvents when the fluid is passed through by some force, which for us is 
centrifugation. As stated before, the type of sorbent used for solid phase extraction 
depends on the resources available and the chemistry needed. The PP fiber surface is 
hydrophobic so its surface chemistry is not easily altered by pH and has minimal binding 
via electrostatic interactions to other predominantly charged species in biological sample 
matrices as well as minimal interactactions with the extremely negatively charged 
backbone and hydrogen bonding of nucleic acids. Another advantage of the PP 
hydrophobic material has shown to be easily modified via protein adsorption[104] which 
works well to use them as a simple fluidic platform. C-CP fibers have already 
demonstrated platform performance being used in other applications for protein[104, 105] 
and metal extraction[106], and purifying proteins by extracting them from high salt 
solutions for MALDI anaylsis[107] and have extracted analytes from complex matrices 
such as urine and saliva[104] and lysate[108] Similar shaped fibers have been used as 
packing materials for column chromatography, where their fluid transfer properties 
ameliorate high back pressures otherwise required for large-scale preparative column 
chromatography[109-112] Previous work done using PP C-CP have minimized non-specific 
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adsorption and have successfully and selectively extracted proteins from buffer and 
lysate if the proteins are in the presence of Tween-20[108]. 
 The fiber surfaces can be easily modified via protein adsorption for specific 
functionality and can be used as a highly selective solid support for a range of affinity 
capture assays and selective solid phase extractions. The fibers in the following chapters 
were modified with neutravidin via adsorption for specific recognition of biotinylated 
molecules. The avidin-biotin interaction is the strongest non-covalent binding interaction 
in nature with a Kd on the order of 10-15 M. Neutravidin, is the deglycosylated form of 
avidin, and deglycosylation helps minimize non specific binding unlike avidin and raises 
the isoelectric point to a more neutral value (6.3) to give it good solubility in aqueous 
solutions. Biotin labeled molecules are good for protein labeling because biotin is small 
enough not to disrupt the conformation or alter the proteins activity. Most proteins and 
nucleic acids contain or can be easily modified with primary amines or carboxylic acid 
groups that can be easily labeled with biotin. This highly stable interaction between 
biotin and avidin and its similar analogues has been exploited and used in various assays 
where the solid phase is modified with an avidin-like protein in order to bind biotin 
labeled molecules. Using this, the following studies in this thesis reports a proof of 
principle demonstration of a fluidic fiber platform for selective extraction of 
biomolecules by modifying the fibers with NAv via protein adsorption followed by the 
addition of a specific biotinylated analyte recognition moiety.   
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In the following chapters, individual microscopic PP C-CP fibers are bundled and 
pulled into a spectroscopically clear (visible spectrum) 0.8 mm capillary FEP tubing that 
was then cut into 0.5 cm pieces and loaded into the narrow end of a 200 ul micro-pipet 
tip. When fiber surfaces are modified with molecular recognition elements, each fiber-
filled tip becomes a platform for molecular recognition solid phase extraction or assays. 
The pipet tip acts as a reservoir for analyte addition. Results reported here describe 
application of neutravidin modified PP C-CP fibers to extract and detect nucleic acids 
and proteins. Chapter 2 goes over making a selective solid phase modified with 
biotinylated [dT]20 for mRNA extraction that is also coupled with on-fiber fluorescence 
detection where the mRNA is probed with complimentary fluorescent oligos. Chapter 3 
discusses the application of PP C-CP fibers for pull-down assays and comparing protein 
recovery between fibers and streptavidin conjugated magnetic microspheres as well as 
on-fiber fluorescence detection of the protein of interest.  This new fiber configuration is 
distinguished by its simple low-tech design, speed, flexibility, and low cost. 
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CHAPTER TWO 
AN INTEGRATED FLUIDIC PLATFORM FOR EXTRACTION AND DETECTION 
OF SIMULATED mRNA ON CAPILLARY-CHANNELED POLYMER FIBERS 
With the completion of whole genome sequencing, nucleic acids have found use as 
biomarkers in a variety of applications such as molecular diagnostics[113-124] forensics[125-
127] gene expression profiling[128-131] detection of biowarfare agents[132] and environmental 
analysis[133]. Depending on the application, nucleic acids have been generally extracted 
onto silica and anion exchange solid phases by hydrogen bonding and electrostatic 
interactions or by biomolecular recognition via complimentary base pairing of a target 
nucleic acid strand to an immobilized nucleic acid modified solid support. The 
widespread utility of nucleic acid detection is in part due to the development of 
inexpensive, simple, rapid, low-tech, microfluidic devices for easier sample preparation 
by solid phase extraction of nucleic acids. Molecular biology has revolutionized the field 
of bacterial diagnostics as a rapid alternative over bacterial culture using the pathogens 
own DNA and RNA as biomarkers to identify and make definitive diagnosis of bacterial 
species and its resistance in only a few hours.  
A rapid, low-tech and low cost polymer solid support was modified for selective 
extraction and highly sensitive detection of simulated mRNA using a novel fiber-based 
microfluidic platform made from low cost textile fibers. The simulated mRNA was 
designed with oligonucleotide sequences coding for a region of either TNF-α or β-actin 
specific mRNA sequences including a [dA]20 tail as a stand-in for the complete mRNA. 
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Extraction and detection was integrated on the fibers with downstream analysis that 
consisted of on fiber fluorescence detection of the simulated mRNA. Integration of 
extraction and detection is desirable because it minimizes sample handling, which can 
lead to sample contamination and degradation. Although visual detection is practical for 
those areas, it is not as sensitive as alternative detection strategies. A laboratory in a 
hospital or clinicians office has moderately skilled staff that could still achieve rapid 
processing using simple low-cost designs, but also be able have access to instrumentation 
for better sensitivity using fluorescence, electrochemical, or chemiluminescence 
detection[43, 134-145]. 
Experimental Section 
Materials 
Neutravidin (NAv) was purchased from Thermo Scientific and diluted to 60 ppm into 
phosphate buffer saline (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM 
KH2PO4, pH 7.4) for all experiments. For a blocking reagent, previous research shows 
adding Tween-20 (Rockland) to PBS (PBS-T) at a final concentration of .01% (v/v) 
sufficiently reduced non-specific binding[108] All DNA oligonucleotides were purchased 
from IDT (IA) and diluted into PBS-T. Biotinylated [dT]20 was diluted to 1 uM in PBS-T 
for all experiments.  
The PP fibers (Eastman Chemical) were constructed into “tips” by using protocols 
referenced elsewhere but with slight modifications[104]. Briefly, 470 PP fibers were 
manually wound using a rotary counter and rinsed with 95˚C water, MeOH, ACN, and 
milliQ water. Once the fibers dried, the fibers were pulled into 30 cm long, 0.8 mm 
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optically clear (visible spectrum) fluorinated ethylene propylene (FEP) capillary tubing 
(Cole-Parmer). Tips were created by cutting the bundle down to individual 0.5 cm pieces 
leaving a 6 mm gap to fit it to the end of a 200 ul micropipette tip that was then cut and 
fitted to the end of a 1 ml micropipette tip that acted as the reservoir for fluids to be 
passed through the fiber spin columns during centrifugation. A 15 ml tube collected the 
effluent. The apparatus was completed by fitting the tip and reservoir micropipette tip 
assembly through a hole that was formed by drilling into the top of the 15 ml tube lid.  
Experimental outline 
Each functionalization step (including washes in between each reagent addition) for 
all experiments used 100 ul of volume (except for small volume experiments which used 
10 ul) and spun at 220 X g for 1 min at 21˚C. PP C-CP fiber tips were modified by serial 
addition of NAv, biotinylated [dT]20, and either a fluorescent and non-fluorescent [dA]20. 
All other experiments for on fiber detection of simulated mRNA were done by similar 
modification with NAv, and biotinylated [dT]20, but with serial addition of simulated 
mRNA and complementary fluorescent labeled probes (500 nM). All reagents used were 
kept on ice until needed. 
Data acquisition and analysis 
With the fibers still packed into the tubing, the fluorescence from the fiber tips was 
detected and imaged at 2X magnification (2X/.08 NA UPlan) using an eppifluorescence 
microscope (Olympus IX71) connected to an Orca-ER (Hamamatsu) CCD camera and 
Xe arc lamp excitation source. The fluorescence for fluorescein amidite (FAM) and 
Texas Red labeled oligos was detected using 494 ex/ 531 em filter and 575 ex/624 em 
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filter respectively. The fluorescent 
fiber images were collected and 
quantified using Slidebook 5.0. 
Each experiment used 3 fiber tips 
and the average fluorescence 
intensity from each single fiber tip 
was averaged over the triplicate 
tips. All plots were generated using 
Kaleidaraph 4.1 (Synergy 
Software).  
Results and discussion 
Solid phase extraction can be 
made more selective by modifying 
the solid support with specific 
analyte recognition moeities. A 
model system was first constructed 
to generally extract mRNA on the 
fibers. Most mRNA found in 
mamillian cells are tagged with a 
polyA tail. This made it easy to design and test a model system that used a biotinylated 
[dT]20  tethered onto the C-CP fibers via NAv to extract the mRNA by [dA]20/[dT]20 
B  
1	  mm 
Figure 2.1. Fiber tips are a platform for 
mRNA extraction. 0.5 cm fiber tips in 
triplicate. A Representative images. The top 
left panel shows a fiber that was treated with 
NAv followed sequentially by biotin [dT]20, 
and a FAM labeled [dA]20. The center and 
right most panel show no fluorescence. Both 
tips were treated with Nav, but the center one 
was treated with a FAM lableled [dA]20 but 
had no biotin[dT]20, and the right had 
biotin[dT]20 but a non- fluorescent [dA]20 B 
Barplot of the average fluorescence intensity 
from the fiber tips with standard deviation 
bars. The inset shows the fluorescence from 
the two controls.  
B 
A 
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hybridization. A FAM labeled [dA]20 was then added as a fluorescence indicator for 
[dA]20/[dT]20 hybridization.  
As shown in Figure 2.1 successful 
hybridization was achieved with 
significant fluorescence associated with 
fiber tips treated with NAv, biotinylated 
[dT]20 and the [dA]20 fluorescent labeled 
oligo, but not with tips in the absence of 
biotinylated [dT]20. The data also shows 
very minimal non-specific binding of the 
FAM labeled [dA]20 compared to a 
control where a non-fluorescent [dA]20 
was used which suggest that DNA 
oligos (in the presence of PBST) do not 
adsorb to the PP fiber surface also 
suggesting the presence of adsorbed 
NAv on fiber surface, and demonstrates 
that adsorbed NAv can be used to tether 
biotin-linked recognition elements to the 
fibers as a platform for mRNA 
extraction.  
 C-­‐CP	  Fiber 
 NAv 
Bio 
 NAv 
Bio 
 NAv 
Bio 
Figure 2.2. Illustration depicting the 
hybridization model used for on-fiber 
extraction and detection of synthetic 
mRNA. The PP fiber was modified with 
NAv via adsorption followed by the serial 
addition of biotinylated [dT]20, simulated 
mRNA, and complimentary fluorescent 
labeled probe. 
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mRNA extraction and detection 
was then integrated on the fibers by 
probing the simulated mRNA with a 
complementary fluorescent labeled 
probe. Integration of extraction and 
detection is desirable because it 
minimizes sample handling, which can 
lead to sample contamination and 
degradation which is especially 
important when handling nucleic 
acids. The model was constructed as a 
nucleic acid hybridization sandwich 
configuration (Figure 2.2) with 
biotinylated [dT]20 tethered to the 
NAv modified fiber surface followed 
by the addition of simulated mRNA 
tagged with a polyA tail, then probing 
with a complementary fluorophore 
labeled oligonucleotide. The simulated mRNA was designed with oligonucleotide 
sequences coding for a region of either TNF-α or β-actin specific mRNA sequences 
including a [dA]20 tail as a stand-in for the complete mRNA.  
A 
Figure 2.3. Successful integrated on-fiber 
extraction and detection of synthetic 
mRNA. Representative images and barplots 
(with standard deviation bars, n=3) of the 
fiber tips at different amounts of added A 
TNF-α and B β-actin simulated mRNA. 
LOD was calculated to be 260 and 140 fmol 
for TNF-α and β-actin respectively. 
 
 
B 
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By using the model system 
described above, simulated TNF-
α (Figure 2.3A) and β-actin mRNA 
extraction and fluorescence detection 
was successfully integrated (Figure 
2.3B) directly on the fibers. Fiber tips 
were modified by serially spinning 
through NAv and biotinylated [dT]20 
followed by treatment with different 
amounts  of either simulated TNF-α or 
β-actin; bound simulated TNF-α and 
β-actin were then detected via 
complementary FAM and Texas Red 
labeled probes. The two probes were 
linked to spectrally separate 
fluorescent dyes (FAM and Texas 
Red) to allow independent detection of 
both TNF-α and β-actin, and detected 
via their respective dye’s different emission.  The LOD for on-fiber detection of TNF-α 
and β-actin was calculated to be 260 and 140 fmol respectively. Figure 2.3 also shows 
very low fluorescence associated with tips not exposed to the simulated mRNA oligos. 
 
  A 
B 
Figure 2.4. Two-plex detection of synthetic 
mRNA with fmol LOD. Representative 
images and barplots (with standard deviation 
bars, n=3) of the fiber tips at different 
amounts of added A TNF-α and B β-actin 
simulated mRNA. LOD was calculated to be 
90 and 140 fmol for TNF-α and β-actin 
respectively. 
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Instead, those tips were treated with 1 
uM of randomly generated oligo. An 
ideal assay would allow detection of 
multiple analytes in a single assay. 
The advantage of using fluorescence 
detection is the capability to be able to 
detect multiple mRNAs on a single 
fiber tip to maximize throughput of 
measuring multiple gene sequences 
simultaneously. Using the same 
model system, fluorescence was 
detected for both simulated β-actin 
and TNF-α on the same tip. Both β-
actin and TNF-α were diluted together 
where β-actin was concentrated 10 
fold more than TNF-α. The fibers 
were modified with NAv and 
biotinylated [dT]20 followed by the 
addition of the TNF-α/β-actin mixture and lastly a mixture of the complimentary 
fluorescent labeled probes. Figure 2.4 demonstrates that fiber tips can be multiplexed 
still yielding low LOD of 140 and 90 fmol for β-actin and TNF-α respectively.  As many 
as ten genes could be detected in one tip if individual detection probes were labeled with 
 A 
B 
Figure 2.5. On-fiber detection of small 
volumes. Representative images and barplots 
(with standard deviation bars, n=3) of the 
fiber tips at different amounts of added A 
TNF-α and B β-actin simulated mRNA. 
LOD was calculated to be 400 fmol for both 
TNF-α and β-actin. 
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different quantum dots with individual emission wavelengths[146] Another advantage of 
microfluidics is the ability to use small volumes. The fibers, when packed together into 
the capillary tube make narrow channels a few tens of micrometers wide. Figure 2.5 
shows that we can still extract and probe the simulated mRNA using 10 ul volumes with 
400 fmol LOD for both TNF-α and β-actin.  
Conclusion 
An inexpensive, simple, low-tech fluidic fiber solid phase was successfully 
demonstrated for integrated extraction and detection of nucleic acids using PP C-CP 
fibers with 100s of fmol LOD using fluorescence detection. The speed is notable where it 
only takes 1 min per centrifuge spin for each molecular addition. Hence, the entire 
process (NAv adsorption, tethering of [dT]20, mRNA capture, and detection probe 
hybridization) can take as little as six minutes outside of pipetting and image collection. 
The PP also has minimal non-specific binding of the DNA oligos in the presence of 
PBST. The method requires only an imaging apparatus and centrifuge, and is therefore 
likely to be of use in point of care or near point of care applications. For future directions 
to reduce costs and data acquisition time, we envision adaptation to visual on-fiber 
detection by substitution of fluorescent dyes used here for visible dyes (blue dextran) or 
gold nanoparticles[80] This data, together with other publications using C-CP fibers, 
suggest that the fibers can be used as a platform for a variety of other selective extraction 
of proteins and metals from complex biological fluids and matrices. 
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CHAPTER THREE 
COMPARING MODIFIED CAPILLARY-CHANNELED POLYMER FIBERS FOR 
SELECTIVE PROTEIN EXTRACTIONS AND RECOVERY WITH STREPTAVIDIN 
CONJUGATED MAGNETIC BEADS  
Protien-protein interactions inside a cell act as cues that mediate cellular function and 
gene expression[147-150]. The most common tools used for confirming and discovering 
specific protein-protein interactions inside cells are yeast two hybrid (Y2H) [150, 151], 
phage display[152, 153], tandem affinity purification[151], and pull-down or 
immunoprecipitation assays.  
A pull-down assay is another in-vitro affinity purification method used to help 
confirm or discover stable protein-protein interactions from a cell lysate. Proteins are 
purified and/or isolated out of solution (usually cell lysate) by affinity to antibodies (for 
immunoprecipitation and co-immunoprecipitation assays) or other proteins (for pull-
downs assays) immobilized to a solid support. The gold standard solid phases used for 
these assays (especially for small scale) are micron-sized porous agarose[49, 154] or non-
porous magnetic beads conjugated to specific affinity tags to immobilize proteins and 
antibodies to the surface[154, 155].  
A pull-down assay confirms or discovers specific protein-protein interactions by 
selective extraction using biomolecular recognition and requires a solid support that can 
be easily modified for specific functionality. The solid support is usually modified with a 
protein, known as the (“bait”), which is known to interact and bind specifically with high 
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affinity to the target protein (“prey”) in a complex mixture (eg. lysate). “Bait” proteins 
are immobilized to a modified solid support via an affinity tag. Fusion of a glutathione-S-
transferase (GST) or multiple histidines are standard “bait” protein affinity tags used for 
many protein pull downs[49, 156, 157]. 
Beads have advantages of high binding capacity due to either increased surface area 
of their porous structure such as the case for agarose beads, or an effectively small 
surface to volume as is the case for non-porous magnetic beads. Another advantage is the 
ease of use for small scale, high throughput, and parallel measurement. However, binding 
can be limited by diffusional mass transfer, which can require long equilibration times for 
dilute proteins especially in viscous solutions such as lysate. Protein pull-downs could be 
performed more rapidly with higher capture efficiency using conditions that promote 
mass transfer, such as microfluidics for higher binding efficiency and recovery. 
The C-CP fiber packed micro spin column do not compare to the surface area of 
porous bead packed columns, but Marcus and coworkers have found that the nonporous 
nature of the fibers allow for more convective mass transfer (C-term) of proteins, 
meaning potentially more surface area exposed in a dynamic situation, promoting rapid 
mass transfer and higher binding efficiency compared to beads for pull-down assays for 
dilute proteins in lysate.  
For our work, wound PP C-CP fibers packed into 0.8 mm FEP tubing.  The resulting 
“fiber bundle” was then adapted to be used as a mini-spin column by cutting into 0.5 cm 
pieces of the 30 cm “fiber bundle” and fitted onto the end of a micropipette tip.  In this 
case, the pipet tip served as a reservoir for fluids to be passed through the fiber during 
 22 
centrifugation. The fluidic fiber format has other advantages. For example, the polymer 
nature of C-CP fibers allows them to be stable at many different pHs and inert to most 
aqueous solvents. The resulting microfluidic assay platform is inexpensive, easily 
constructed, and easy to use since most of the equipment is commonly found in most 
labs, such as a centrifuge, micropipette tips, and centrifuge tubes. Not too mention, 
several assays can be performed in parallel. The numbers of assays are just limited by the 
number of slots available in the centrifuge rotor.  
The study here demonstrates a protein pull-down assay using PP C-CP fiber spin 
columns. Proteins bound on the platform will be either be eluted off the solid phases and 
analyzed by SDS-PAGE or probed by fluorescent labeled proteins for on-fiber detection. 
As a proof of principle assay, we demonstrated platform performance using the anthrax 
toxin receptor protein capillary morphogenesis protein 2 (CMG2) as the “bait” and 
anthrax protective antigen (PA) as the “prey” protein. In vivo, PA binds to CMG2 and 
mediates entry of anthrax toxin into the cell[158, 159]. Pull-down performance was 
compared to that obtained in a similar assay using streptavidin coated magnetic beads.  
We hypothesized that the fibers will outperform the beads in cell lysate, due to the mass 
transfer advantages of fluidic flow in the fiber channels.  
Experimental Section 
Materials and Methods 
NAv was purchased from Thermo Scientific and hydrated with doubly deionized 
water (ddH2O) into a stock of 2 mg/ml. NAv was then diluted into PBS (Cellgro) for 
experiments. HEPES buffer saline (HBS) was used to dilute biotinylated-CMG2 and PA. 
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HBS was prepared by dissolving NaCl (150 mM), HEPES (50 mM), MgCl2 (1 mM) in 
ddH2O, and the adjusting the pH up to 7.9 with 10 M NaOH.  A 1% BSA (Fraction V, 
OmniPur) stock solution was made by dissolving BSA into PBS. The final blocking 
solution was further diluting BSA into PBS to .1% along with Tween-20 (Rockland) for a 
total of .1% BSA (w/v)  and .01% Tween-20 (v/v) in the blocking solution. NAv-DyLight 
(Pierce) was hydrated into a 1 mg/ml stock with ddH2O. Hydrophilic streptavidin 
magnetic particles (4 mg/ml) were purchased from New England Biolabs. SDS-PAGE 
Express pre-cast gradient gels (4-20%) were purchased from GenScript.  
Fiber bundle and spin column construction 
The PP C-CP “fiber bundles” were constructed similarly to the method listed above 
Protein preparation and labeling 
Protein preparation and labeling are explained more in detail elsewhere[160, 161]. 
Maleimide functionalized Alexa Fluor 546 and biotin were added to PA and CMG2C40 
respectively as described previously[161].  
Functionalizing fibers with NAv-DyLight 
The first round of experiments was to show NAv-Dylight binding and compared it to 
bare fiber columns with no NAv-Dylight spun through and another set treated first with a 
molar equivalent of BSA. Each fiber column was functionalized by serially spinning 
through 200 ul PBS, 400 ul NAv-DyLight (.05 mg/ml), and 1 ml PBS. The control group 
of bare fiber columns had used 400 ul PBS in place of NAv-Dylight and the other set was 
treated with a molar equivalent of BSA followed by treatment with NAv-Dylight.  
 24 
A second experiment wanted to determine NAv stability on the fibers in the presence 
of blocking solution and its individual components. This was done by visualization and 
monitoring fluorescence using NAv-Dylight. Both bare fiber controls and NAv-Dylight 
treated fibers were serially treated with the next step of 1 ml of .1% BSA, .1% BSA with 
.01% Tween-20, .01% Tween-20, and 1 ml PBS followed by a 1 ml PBS wash. The 
fluorescence from the fibers were measured and imaged on-fiber before and after 
treatment with blocking solution using the fluorescence microscope. The fluorescence on 
the fiber after treatment with blocking solution and its individual components was the 
calculated as a ratio of the initial fluorescence of NAv-Dylight before treatment with the 
blocking solution. 
Biotinylated-EGFP binding experiments 
To measure if biotinylated molecules bound to the fiber as well as amount, 
biotinylated-EGFP was donated as a generous gift from Dr. George Chumanov to be used 
for easily visualization and quantification of biotin bound to fibers and streptavidin 
comjugated magnetic beads.  
The first experimented was to determine biotinylated-EGFP binding to the NAv 
modified fiber tips. For this first NAv was added to the fibers (.05 mg/ml, 400 ul), 
followed by 1 ml PBS wash, and the final biotinylated-EGFP solution (50 pmol, 400 ul), 
followed by a final 1 ml PBS wash. Two other control groups had buffer used in place of 
biotinylated-EGFP and the NAv modification step. The EGFP fluorescence was then 
visualized on the fibers using a fluorescence microscope.  
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The second experiment used biotinylated-EGFP to measure the amount of biotin 
binding (pmol) to fibers and streptavidin magnetic beads by measuring and comparing 
the fluorescence of the unbound biotinylated-EGFP in the fiber flow through and post 
incubated bead solution to an initial EGFP fluorescence value that was added to both 
fibers and beads. The fluorescence was measured using a plate reader (Tecan 
instruments).   The values left over were then taken as a percentage of the initial 
fluorescence and calculated to its corresponding pmol value based off of 100% unbound 
EGFP fluorescence being 50 pmol of biotinylated-EGFP. The values obtained from this 
experiment were used later on to adjust and normalize the amount of streptavidin 
magnetic beads to biotin binding.  
Data acquisition for fluorescence detection 
Fluorescence from the fiber columns was imaged with fibers still packed into the FEP 
tubing at 2X magnification, using a fluorescence microscope (Olympus). The excitation 
and emission filters were set to 575 ex /624 em for Dylight and Alexa Fluor 546 
fluorescence detection. Filters were set to 494 ex/531 em for EGFP on fiber fluorescence 
measurements.  
Probing CMG2 with PA-AlexaFluor 546 
All fibers (in triplicate) were treated with 200 ul PBS, 400 ul NAv (.05 mg/ml), 1 ml 
blocking solution, 1 ml PBS, 400 ul biotin-CMG2 (50 pmol) (Buffer for negative 
control), 1 ml HBS, 400 ul PA-AF546 (various concentration) and 1 ml HBS. The fibers 
were then imaged using the fluorescence microscope.  
Fiber and bead comparison of PA pull down from lysate 
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Four fiber bundles (.5 cm) were assembled into the tip/spin column apparatus where 
one of the four was a control with no biotin-CMG2. Each bundle was to receive 
periplasmic lysate but at different volumes (100 ul, 1 ml, and 10 ml). All fiber bundles 
were functionalized with 200 ul PBS, 400 ul NAv (.05 mg/ml), 1 ml blocking solution, 1 
ml PBS, 400 ul biotin-CMG2 (HBS for control), 1 ml HBS, lysate (various volumes), and 
1 ml HBS.  The control fiber bundle received 1 ml of periplasmic lysate. Four eppendorf 
tubes each contained 60 ug of hydrophilic streptavidin coated magnetic beads. The 
amount of beads was normalized to bind the same amount of biotin as the fibers 
(experimentally determined to be 11 pmol). First, the beads were washed separately in 
their respective tubes with 200 ul PBS (incubated 1 min. X 3). The functionalization 
method was similar to the fibers where each tube of beads was to receive the lysate at 
different volumes with one of the four as a control with no biotin-CMG2. All 4 tubes of 
beads were functionalized with the same volumes and reagents as fibers minus the NAv 
since they were already functionalized with streptavidin. All incubations for volumes less 
than 1 ml were 1 min and 2 min for 1 ml except 20 min incubation for the 10 ml lysate 
step. Both fibers and beads had the proteins eluted off with 30 ul of 5% SDS (in PBS). 
The 30 ul elutions were analyzed by SDS-PAGE and loaded onto a gel along with a 1 ug 
PA standard and molecular weight ladder.  
SDS-PAGE gel 
A GenScript Express 10 well pre-cast gradient gel (4-20%) was used for analysis. The 
1X running buffer was made by dissolving Tris base (6.06 g), MOPS (10.46 g), SDS (1.0 
g), and disodium EDTA (.30 g) diluted up to 1000 ml with deionized water. The voltage 
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was constant at 140 V. The loading buffer was .3125 M Tris-Cl pH 6.8, 10% SDS, 50% 
glycerol, with 2-mercaptoethanol. Samples were loaded by adding 30 ul of elution plus 
6ul of 5X loading buffer. The samples, including the PA sample were heated at 95˚ C for 
5 min before loading.  
Results and discussion 
Most pull-downs have a “bait” protein tethered to a solid support that is specific to a 
particular protein (“prey”). The “bait” protein is either recombinantly fused to another 
protein or tagged to a molecule for it to be tethered to the surface of the solid phase. Pull-
downs can be performed on either a large scale, which then chromatography columns 
packed with microbeads coated with the “bait” protein or just using the beads as 
suspensions in tubes for small-scale reactions. Small scale makes it easier for higher 
throughput for parallel assays. Beads are available pre-conjugated to either protein A or 
G to immobilize the “bait” IgG for immunoprecipitation assays or tethered to a 
glutathione protein to immobilize glutathione-S-transferase fused “bait” proteins[154]. This 
helps for selective purification and to not to hinder the binding activity of the “bait” 
towards specific protein binding partners. To not hinder the “bait” (CMG2) binding 
activity towards PA, CMG2 was tagged with a biotin molecule. To tether it on the 
surface, NAv was physically adsorbed to the PP fiber surface. Adsorbed NAv on the fiber 
surface will then serve to tether any biotinylated recognition moiety, via the tight NAv-
biotin interaction. PP fibers have been previously shown to interact with proteins via 
strong hydrophobic interactions. They have also been used in reverse phase 
chromatography where the only way to remove proteins from the PP surface was by 
 28 
increasing the hydrophobicity of the 
mobile phase. Both these results 
indicate that the proteins physically 
adsorb to the PP surface and by way 
of hydrophobic interactions. 
However, there are no studies 
showing NAv adsorption to PP C-CP 
fibers. To demonstrate that NAv 
adsorbs to the hydrophobic PP fiber 
surface, experiments were conducted 
with fluorescently labeled NAv 
(NAv-Dylight). Images and the 
fluorescence of the Dylight were 
measured directly from each fiber 
column still packed into the FEP 
tubing using a fluorescence 
microscope. Using NAv-Dylight 
showed that BSA has to adsorb to the 
fibers because fibers treated with BSA 
before NAv-Dylight had a 
significantly lower fluorescence than fibers that were treated with just NAv-Dylight with 
no BSA pretreatment. Fluorescent images of fibers treated with NAv-Dylight show 
Figure 3.1. Determining NAv adsorption 
and stability to PP C-CP fibers. A 
Representative fiber images of NAv-Dylight, 
BSA pretreatment, and bare fiber with 
corresponding barplot of fluorescence 
intensity (n=3) with standard deviation bars. 
B Barplot of on fiber detection of Dylight 
fluorescence as a ratio of before and after 
treatment. 
1	  mm A 
B 
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significant fluorescence versus a negative control (NC) of bare (no protein) treated fiber 
(Figure 3.1A) indicating that NAv adsorbs to the PP surface and from the fluorescence 
from the fiber shows an even coating. NAv stability was tested against the individual and 
combined components of the blocking solution (Tween-20 and BSA) compared to a 
control of just PBS. Upon the addition of the blocking step NAv-Dylight fluorescence 
decreases significantly compared to the fiber image before the addition of the blocking 
solution (Figure 3.1B). The control (PBS treated fibers) showed the least change while 
Tween-20 decreased Dylight fluorescence the most. This suggests that both BSA and 
Tween-20 compete off NAv-Dylight. BSA contains hydrophobic groups, and the Marcus 
and coworkers have showed BSA interaction on PP fibers by physical adsorption. 
Tween-20 is a non-ionic surfactant with hydrophobic groups and a long hydro-carbon 
chain. Both then have the possibility of binding to the PP surface, which is why they were 
originally thought to be used as blocking agents. However, they seem to have stronger 
interactions with the PP fibers and compete off the NAv. Therefore, different blocking 
agents or concentrations of the BSA and Tween-20 need to be used so as not to compete 
off the NAv. However it is still uncertain whether they strip off weakly bound 
interactions and the stronger bound protein remain at the surface, or if it is stripping off 
weakly bound Dylight dye. Protein activity may be reduced by the conformational 
changes when adsorbed to a surface. Therefore, as its conformation changes, then its 
binding activity can decreases. Since PP is hydrophobic, NAv would probably have to 
unfold to expose some of its hydrophobic patches and bind to the surface of PP with 
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multiple van der Waals interactions. This could interfere with its binding activity towards 
biotin.  
To test if NAv was still active and 
bound biotin after adsorption, EGFP 
was tagged to a biotin molecule to 
easily visualize the biotin binding and 
to normalize the amount of beads 
needed to compare to the fibers. The 
fluorescence of EGFP was measured 
on the fiber tips using a fluorescence 
microscope. The presence of 
fluorescence on the fiber would then 
indicate that biotin bound to the 
NAv. The data showed (Table 3.1) 
that biotin-EGFP bound to the NAv. Bead quantity was chosen with equivalent biotin-
binding based on the results of an experiment to determine biotin binding between fiber 
columns and beads. Biotin binding was compared between streptavidin conjugated 
magnetic beads and NAv modified fiber tips. The amount bound was determined by 
measuring fluorescence of biotin-EGFP added to fibers and beads (the fluorescence value 
was considered 100%) and measuring the fluorescence from the flow through of the 
fibers and the biotin-EGFP after incubation with the magnetic beads which the 
fluorescence was taken as a percentage of the initial fluorescence measurement. The 
Table 1. pmol of biotinylated-GFP bound 
to fibers and streptavidin magnetic beads 
(n=3) 
Figure 3.2 NAv modified C-CP fibers 
binds biotinylated EGFP. Top Table of the 
pmol bound to both fibers and beads (n=3). 
Bottom Representative fiber images of EGFP 
fluorescence. Far left panel was treated with 
NAv and biotin-EGFP, middle panel only 
NAv, and right panel biotin-EGFP.  
1 mm 
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magnetic beads were added to compare the total surface area of the fibers, and showed 
that more biotin-EGFP bound to the magnetic beads than the fiber tips (Figure 3.2).  
Fluorescence has its merits in 
analytical detection because of its 
sensitivity and low limits of 
detection since the light that is 
detected is mostly from the 
emitting molecule. For this case a 
model system was designed to 
selectively extract and detect 
protein-protein interactions by on 
fiber fluorescence detection. The 
“bait” protein (CMG2) was 
biotinylated and tethered to the 
NAv modified fiber via biotin-
NAv interaction, and the “prey” PA was tagged with a fluorophore (PA-AF546). 
Different concentrations of purified labeled PA were spun through the biotinylated-
CMG2 coated fibers, and the  fluorescence was measured on the fibers using a 
fluorescence microscope (Figure 3.3).  Only fibers treated with all three proteins (NAv, 
biotinylated-CMG2, and PA-AF546) fluoresced compared to negative controls, 
indicating specific interaction of PA to CMG2 tethered on the fiber surface. This also 
verifies previous experiments that NAv and biotinylated-CMG2 would have to be both 
Figure 3.3. On-fiber detection of CMG2-
PA protein interaction. Different 
concentrations of labeled PA added to CMG2 
modified C-CP fibers. Barplot of 
fluorescence from labeled PA  bound to 
CMG2 with standard deviation bars (n=3).  
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functionalized near the fiber surface because there was minimal fluorescence seen for 
fiber columns not treated with either NAv or biotinylated-CMG2. However, most pull-
down assays are performed in more complex solutions with other proteins, and non-
specific binding goes up the more concentrated the proteins are in the solution. Pull-
downs are typically performed in complex solutions such as lysate, in which small 
quantities of target/analyte protein are presented in high concentrations of other proteins. 
To demonstrate specific capture of PA by CMG2 in a complex solution, we treated 
CMG2-modified fiber spin columns with perriplasmic lysate from PA-expressing cells. 
In this case, columns were treated with different volumes of lysate (.1-10 ml), spanning 2 
orders of magnitude. Bound proteins were eluted from tips and visualized using SDS 
PAGE (Figure 3.4).  Comparison of eluted protein with a PA standard (lane 2) shows 
that fiber columns capture PA out of lysate. There was much more non-specific binding 
for the fiber columns treated with 10 ml of lysate. Single NAv subunits were also 
visualized on the gel for the fiber columns since they matched near 17 kDa on the 
molecular weight ladder. There was also faint bands seen near 26 kDa for the fiber 
columns treated with biotinylated-CMG2, but not seen for the control fiber (not treated 
with biotinylated-CMG2). Also there was not much non-specific binding for volumes 
added under 10 ml, and minimal PA non specific binding to both fiber column and beads 
that were not treated with biotinylated-CMG2. 
For comparison, similar experiments were carried out using streptavidin-modified 
magnetic beads. The beads were incubated with lysate for time equivalent to the fiber 
spin time. As shown in Figure 3.4, quantities of PA pulled down out of lysate, onto the 
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beads, are roughly similar for fiber tips and CMG2-modified beads. There was also much 
less non-specific binding for the beads 
incubated with the 10 ml of lysate. 
Conclusion 
It was originally hypothesized that 
the mass transfer properties of fluidic 
flow in the fiber channels would perform 
better with more efficient extraction than 
diffusion limited assays such as beads 
based on previous fiber data indicating 
increased mass transport of proteins for 
chromatographic separations. However, 
in the end, recovery from both fibers and 
streptavidin magnetic beads were similar 
as shown from the band intensities in the 
gel. It is not fully understood as to why 
that is. This could be due to mass 
transfer limitations or some sort of 
kinetic effect concerning the orientation 
and density of the “bait” CMG2 
immobilized onto the fibers. Even 
though affinity between the 
95 
17 26 
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Figure 3.4. SDS polyacrylamide gel of 
protein(s) eluted from CMG2-modified 
fiber bundles and beads.   Fiber tips 
modified with NAv and biotin-CMG2 were 
treated with lysate from PA-expressing 
cells (0.1 mL (lane 3); 1 mL (lane 4); 10 
mL (lane 5). Lanes 7 – 10 reflect 
corresponding data for NAv-magnetic 
beads modified with CMG2-biotin. Fibers 
and beads were normalized for biotin 
binding to allow comparison of PA capture 
by equivalent CMG2 concentration in two 
different formats. Total bound protein was 
eluted with 5% SDS. The red box (lane 2) 
indicates 1 ug of PA standard; lanes 6 and 
10 reflect eluate from fibers and beads not 
treated with lysate. Protein ladder in far left 
lane was used to verify proteins by 
molecular weight.  
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biomolecular recognition ligand and protein can be high (as for CMG2 and PA), kinetic 
effects on the solid phase can make it appear less so. For example, binding has shown to 
also be dependent upon the orientation and surface density[162-165] of the immobilized 
affinity ligand. The fiber may still have rapid mass transport, but if the “bait” CMG2 was 
not at the optimal density and configuration, the fluid flowing through the fiber channels 
might not allow enough time for the PA proteins to stay at the surface to form the 
necessary bonds. However, depending on the application will also depend on how much 
protein is actually needed. 
It is believed that once these questions are answered, the fibers will be a good 
material for a selective solid support for small scale immunoprecipitation and pull-down 
assays. They have already shown to be selective in a variety of complex mixtures, the 
polymer material makes them chemically stable and resistant to a variety of solvents and 
pH, they do not dry out, can be reusable, and are stable over long term storage, unlike 
beads that over time will eventually aggregate.  
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CHAPTER FOUR 
CONCLUSIONS 
The results in this thesis report successful extraction and on-fiber fluorescence 
detection of protein (from cell lysate) and nucleic acids (with fmol LOD and multiplex 
detection) using a neutravidin modified fiber based fluidic platform made from PP C-CP 
fibers. Protein recovery was similar between fibers and streptavidin conjugated magnetic 
microspheres.  
Widespread use of solid phase extraction is in part due to the development of simple, 
inexpensive, low-tech, easy to use solid phase configurations. The C-CP spin micro 
column is simple and cost effective enough to find widespread utility in many different 
fields for selective solid phase extraction and also find a place in point of care facilities 
for molecular diagnostics. Research to date also shows the use of other fibers and threads 
for solid phase extraction and molecular diagnostics assays as an ongoing effort to design 
simple, compact, fluidic designs from cheap and high abundant materials. The research is 
relatively new and there needs to be more done to better understand how fibers and 
threads can effectively be used in these applications. However the literature and the work 
done using C-CP fibers shows potential for future fiber fluidic sorbent materials and 
configurations that could be utilized for solid phase extraction and molecular diagnostics.    
Although the C-CP fiber material and spin configuration are practical and cost 
effective, there is room for improvement. Based on this work, it is envisioned that nucleic 
acid analysis time can be decreased by coupling visual detection instead of fluorescence 
as well as selectively extracting nucleic acids directly from cell lysate. Future work for 
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selective protein capture and detection by fundamental studies understanding of protein 
affinities, orientation, and ligand surface density on the fibers to ensure optimal protein 
capture efficiency.  
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